Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 25:9:648584.
doi: 10.3389/fped.2021.648584. eCollection 2021.

Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates

Affiliations
Review

Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates

Aparna Patra et al. Front Pediatr. .

Abstract

Delay in closure of ductus arteriosus in postnatal life may lead to serious consequences and complications in an extremely premature neonate secondary to hemodynamic alterations in regional blood flow pattern in various organs. Despite the widespread recognition amongst neonatologists to identify a hemodynamically significant patent ductus arteriosus (hsPDA) early in the postnatal course, there is lack of consensus in its definition and thus the threshold to initiate treatment. Echocardiographic assessment of PDA shunt size and volume combined with neonatologists' impression of clinical significance is most frequently used to determine the need for treatment of PDA. Common clinical signs of hsPDA utilized as surrogate for decreased tissue perfusion may lag behind early echocardiographic signs. Although echocardiogram allows direct assessment of PDA shunt and hemodynamic alterations in the heart, it is limited by dependence on pediatric cardiologist availability, interobserver variation and isolated time point assessment. Electrical cardiometry (EC) is a non-invasive continuous real time measurement of cardiac output by applying changes in thoracic electrical impedance. EC has been validated in preterm newborns by concomitant transthoracic echocardiogram assessments and may be beneficial in studying changes in cardiac output in premature newborns with hsPDA. Alterations in perfusion index derived from continuous pulse oximetry monitoring has been used to study changes in cardiac performance and tissue perfusion in infants with PDA. Near infrared spectroscopy (NIRS) has been used to objectively and continuously assess variations in renal, mesenteric, and cerebral oxygen saturation and thus perfusion changes due to diastolic vascular steal from hsPDA in preterm neonates. Doppler ultrasound studies measuring resistive indices in cerebral circulation indicate disturbance in cerebral perfusion secondary to ductal steal. With recent trends of change in practice toward less intervention in care of preterm newborn, treatment strategy needs to be targeted for select preterm population most vulnerable to adverse hemodynamic effects of PDA. Integration of these novel ways of hemodynamic and tissue perfusion assessment in routine clinical care may help mitigate the challenges in defining and targeting treatment of hsPDA thereby improving outcomes in extremely premature neonates.

Keywords: echocardiogram; electrical cardiometry; hsPDA; near-infrared spectroscopy; physiologic; preterm.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Monitoring of hsPDA in the NICU. fECHO, functional echocardiogram; LA, left atrium; Ao, aortic root; LPA, left pulmonary artery; ASD, atrial septal defect; PFO, patent foramen ovale; LVO, left ventricular output; EC, electrical cardiometry; NIRS, near infrared spectroscopy; cRSO2, cerebral regional oxygen saturation; rRSO2, renal regional oxygen saturation; sRSO2, splanchnic regional oxygen saturation.

Similar articles

Cited by

References

    1. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. (2010) 125:1020–30. 10.1542/peds.2009-3506 - DOI - PubMed
    1. Sung SI, Chang YS, Kim J, Choi JH, Ahn SY, Park WS. Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation. PLoS ONE. (2019) 14:e0212256. 10.1371/journal.pone.0212256 - DOI - PMC - PubMed
    1. Bancalari E. Patent ductus arteriosus and short- and long-term respiratory outcomes. Am J Perinatol. (2016) 33:1055–7. 10.1055/s-0036-1586112 - DOI - PubMed
    1. Clyman RI. Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity. Semin Perinatol. (2018) 42:235–42. 10.1053/j.semperi.2018.05.006 - DOI - PubMed
    1. Jain A, Shah PS. Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates. JAMA Pediatr. (2015) 169:863–72. 10.1001/jamapediatrics.2015.0987 - DOI - PubMed

LinkOut - more resources